Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine — New York, New York

Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine has participated in 1 clinical trials.

Therapeutic areas: CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma.

Sponsors: Celldex Therapeutics.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine?

Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine conducted?

Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine has 1 clinical trials on record. Their work covers CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma.

Is Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine accredited by Crixeo Health?

Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.